Fish Oil Consumption Reduces Hypertriglyceridemia in Psoriatic Patients Receiving Etretinate Therapy

Archives of Dermatology

Volumn 124, Issue 2, 1988, Pages 177-178

  Lowe, Nicholas J ^a   Borok, Michael E ^a   Ashley, Judith M ^b   Alfin Slater, Roslyn B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETINATE; FISH OIL;

CLINICAL ARTICLE; HUMAN; HYPERTRIGLYCERIDEMIA; LETTER; ORAL DRUG ADMINISTRATION; PSORIASIS;

ETRETINATE; FATTY ACIDS; FISH OILS; HUMAN; HYPERLIPOPROTEINEMIA; PSORIASIS;

EID: 0023836746     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1988.01670020009003     Document Type: Letter

References (5)

1. Kaplan RP, Russell DH, Lowe NJ: Etretinate therapy for psoriasis: Clinical responses, remission times, epidermal DNA, and polyamine responses. J Am Acad Dermatol 1983;8:95–102.
2. Simopoulos AP: Summary of the conference on the health effects of polyunsaturated fatty acids in seafoods. J Nutr 1986; 116:2350–2354.
3. Marsden J: Hyperlipidaemia due to isotretinoin and etretinate: Possible mechanisms and consequences. Br J Dermatol 1986;114:401–407.
4. Marsden JR: Reduction of retinoid hyperlipidaemia with MaxEPA. Br J Dermatol 1987;116:450
5. Ziboh VA, Cohen KA, Ellis CN, et al: Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Arch Dermatol 1986;122:1277–1282.